| Table 2. Association of ovarian stimulation scheme with number of clinical pregnancies and live newborns by number of cycles. | ||||||
| Stimulation scheme | No. of clinical pregnancies / No. of cycles (%) | No. of live newborns / No. of cycles (%) | ||||
| IIU + FIV (n=96 cycles) |
dFIV (n=62 cycles) |
Total (n=158 cycles) |
IIU + FIV (n=96 cycles) |
dFIV (n=62 cycles) |
Total (n=158 cycles) |
|
| Menotropins (hMG) (n=69 cycles) |
6/32 (18.8) |
12/37 (32.4) |
18/69 (26.1) |
4/32 (12.5) |
10/37 (27) |
14/69 (20.3) |
| rFSH (n=52 cycles) |
5/52 (9.6) |
-- | 5 /52 (9.6)* |
5/52 (9.6) |
-- | 5/52 (9.6)** |
| rFSH/rLH (n=37 cycles) |
5/12 (41.7) |
12/25 (48) |
17/37 (45.9)* |
5/12 (41.7) |
10/25 (40) |
15/37 (40.5)** |
* In the intergroup analysis it showed a significant difference (p<0.001).
** In the intergroup analysis it showed a significant difference (p=0.002).